Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2003-2006
Title: Michael Schaeffer: Innovator in Multiple Myeloma Treatment
Introduction
Michael Schaeffer is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of multiple myeloma. With a total of 2 patents, his work focuses on innovative approaches to combat this challenging disease.
Latest Patents
Schaeffer's latest patents include groundbreaking methods for inhibiting the proliferation of cells associated with multiple myeloma. One of his inventions involves deletion mutants of the gp130 protein of the IL-3 receptor, which inhibit the binding of Hck tyrosine kinase and the growth of tumor cells, particularly myeloma cells. Another patent describes a means for the treatment of multiple myeloma through the deletion of the Hck binding region in the IL-6 receptor, showcasing his commitment to advancing cancer treatment.
Career Highlights
Throughout his career, Michael Schaeffer has worked with esteemed organizations such as GSF—Forschungszentrum für Umwelt und Gesundheit GmbH. His research has been pivotal in understanding and developing treatments for complex health issues, particularly in oncology.
Collaborations
Schaeffer has collaborated with talented individuals in his field, including Michaela Schneiderbauer and Sascha Weidler. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Michael Schaeffer's innovative work in the treatment of multiple myeloma highlights his dedication to improving patient outcomes through scientific research. His contributions to the field are invaluable and continue to inspire future advancements in cancer treatment.